Abstract
The ratio of signal intensity in T1-weighted (T1w) and T2-weighted (T2w) magnetic resonance imaging (MRI) was recently proposed to enhance the sensitivity of detecting changes in disease-related signal intensity. The objective of this study was to test the effectiveness of T1w/T2w image ratios as an easily accessible biomarker for amyloid beta (Aβ) accumulation. We performed the T1w/T2w analysis in cognitively normal elderly individuals. We applied [11C] Pittsburgh Compound B (PiB)-PET to the same individuals, and Aβ deposition was quantified by its binding potential (PiB-BPND). The subjects were divided into low and high PiB-BPND groups, and group differences in regional T1w/T2w values were evaluated. In the regions where we found a significant group difference, we conducted a correlation analysis between regional T1w/T2w values and PiB-BPND. Subjects with high global cortical PiB-BPND showed a significantly higher regional T1w/T2w ratio in the frontal cortex and anterior cingulate cortex. We found a significant positive relationship between the regional T1w/T2w ratio and Aβ accumulation. Moreover, with a T1w/T2w ratio of 0.55 in the medial frontal regions, we correctly discriminated subjects with high PiB-BPND from the entire subject population with a sensitivity of 84.6% and specificity of 80.0%. Our results indicate that early Aβ-induced pathological changes can be detected using the T1w/T2w ratio on MRI. We believe that the T1w/T2w ratio is a prospective stable biological marker of early Aβ accumulation in cognitively normal individuals. The availability of such an accessible marker would improve the efficiency of clinical trials focusing on the initial disease stages by reducing the number of subjects who require screening by Aβ-PET scan or lumbar puncture.
Abbreviations: Aβ, amyloid beta; AD, Alzheimer's disease; BP, binding potential; CSF, cerebrospinal fluid; FWHM, full-width at half maximum; MRI, magnetic resonance imaging; PET, positron emission tomography; PiB, Pittsburgh Compound B; PiB-BPND, PiB-BP estimates relative to non-displaceable (ND) binding; ROC, receiver operating characteristic; T1w, T1-weighted; T2w, T2-weighted; VOI, volumes of interest
Keywords: Alzheimer's disease (AD), Amyloid-β (Aβ), 11C–labeled Pittsburgh Compound B ([11C]PiB), Positron emission tomography (PET), T1-weighted/T2-weighted magnetic resonance ratio images
Graphical abstract
Highlights
-
•
We examined the T1w/T2w ratio of MR images in cognitively normal elderly subjects.
-
•
Aβ deposition was quantified by [11C] PiB-PET binding potential (PiB-BPND).
-
•
The T1w/T2w ratios were positively correlated with PiB-BPND values.
-
•
We correctly discriminated subjects with high PIB-BPND using the T1w/T2w ratio.
-
•
The T1w/T2w ratio from MRI is a potential biological marker of early Aβ deposition.
1. Introduction
The amyloid beta (Aβ) cascade is currently the most convincing hypothesis for the pathogenesis of Alzheimer's disease (AD), suggesting that the formation of senile plaques followed by the deposition of Aβ are the earliest pathological changes in the disease (Hardy and Selkoe, 2002, Hardy and Higgins, 1992). Recent evidence has shown that amyloid pathology occurs > 20 years before the clinical onset of AD (Bateman et al., 2012, Jack et al., 2013). Therefore, biomarker-based detection of the initial Aβ pathology is important for better clinical management of AD, potentially providing the opportunity to start disease-modifying therapies before the progression stages of AD.
The accumulation of brain Aβ can be assessed by measurement of the Aβ concentration in the cerebrospinal fluid (CSF) or by molecular imaging techniques such as positron emission tomography (PET) using a specific radioligand for Aβ. However, lumbar puncture, needed for the collection of a CSF sample, is associated with the risk of a clinically noxious event and thus is unsuitable as a mass screening tool.
Neuroimaging has the merit of being less invasive. However, PET is relatively expensive, and its availability is limited. Furthermore, PET leads to cumulative radiation exposure of subjects (Tosun et al., 2014).
Magnetic resonance imaging (MRI) is an appealing candidate for the inexpensive and noninvasive identification of surrogate biomarkers for altered brain anomalies in neurological and psychiatric diseases. The ratio of the signal intensities of T1-weighted (T1w) and T2-weighted (T2w) MRI was recently proposed to enhance the sensitivity of detecting changes in signal intensity associated with diseases (Glasser and Van Essen, 2011). Signal intensity changes may be a particularly sensitive measurement, as exhibited by findings in various brain diseases (e.g., infarction and multiple sclerosis), and measuring the signal intensity ratio of T1w and T2w images has conceivable advantages over standard volume/size measurements (Iwatani et al., 2015).
Recently, improved methods have been developed that use the ratio of T1w/T2w MRI images (Ganzetti et al., 2014, Shafee et al., 2015). We hypothesized that the T1w/T2w ratio analysis may also be helpful to detect signal intensity changes due to Aβ accumulation within subjects at pre-clinical stage of AD. To test this hypothesis, we examined the effectiveness of T1w/T2w ratio imaging as an easily accessible biomarker for Aβ accumulation. We applied the T1w/T2w analysis workflow (Ganzetti et al., 2014) to structural MRI data collected in cognitively normal elderly individuals. For comparison to standard PET techniques, we performed [11C] Pittsburgh Compound B (PiB)-PET in the same individuals, and Aβ deposition was quantified by cortical binding potential (PiB-BPND). The main purpose of this study was to develop a new method for screening patients for high accumulation of Aβ deposits by using the ratio of the signal intensities in T1w and T2w images.
2. Materials and methods
2.1. Participants
Thirty-eight cognitively normal older participants were recruited from the local area by poster advertisements. The inclusion criteria were an age of 55–85 years, a mini-mental state examination score of 27 or higher, independent living in the community, and no major structural abnormalities or signs of major vascular pathology on MRI. The exclusion criteria included major neurological, psychiatric, or medical illnesses; the use of medications that affect cognition; and MRI contraindications. This study was carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. The study was approved by the institutional review boards of all of the participating institutions, and all participants gave written informed consent.
2.2. PET and MRI scans
PET and MRI examination methods have been described in detail previously (Yasuno et al., 2016). PET examinations were performed with a Biograph mCT (Siemens, Knoxville Healthcare/Molecular Imaging, TN, USA). [11C]PiB (645 ± 30 MBq) was intravenously injected with 50 mL of saline. A sequence of 33 scans was acquired during the 70 min (4 × 15 s, 8 × 30 s, 9 × 1 min, 2 × 3 min, and 10 × 5 min) after the [11C]PiB injection. All MRI examinations were performed using a 3.0-Tesla whole-body scanner (Signa Excite HD V12M4; GE Healthcare, Milwaukee, WI, USA) with an 8-channel phased-array brain coil. High-resolution three-dimensional T1-weighted images were acquired using a spoiled gradient-recalled sequence (TR = 12.8 ms, TE = 2.6 ms, flip angle = 8°, FOV, 256 mm; 188 sections in the sagittal plane; acquisition matrix, 256 × 256; acquired resolution, 1 × 1 × 1 mm). T2-weighted images were obtained using a fast-spin echo sequence (TR = 4800 ms; TE = 101 ms; echo train length (ETL) = 8; FOV = 256 mm; 74 slices in the transverse plane; acquisition matrix, 160 × 160, acquired resolution, 1 × 1 × 2 mm).
2.3. PET data analysis
PET data analysis has been previously described in detail (Yasuno et al., 2016). [11C]PiB-PET data were corrected for partial volume effects using an algorithm introduced by Muller-Gartner et al. (1992) that was implemented in the PMOD software package (PMOD V.3.3; PMOD Technologies GmbH, Adliswil, Switzerland). The radioactivity levels in six brain regions (the prefrontal cortex, lateral temporal cortex, parietal cortex, anterior cingulate cortex, posterior cingulate cortex, and cerebellum) were obtained with a template-based method for defining volumes of interest (VOI) (Yasuno et al., 2002). Regional time-activity data were analyzed from 35 to 70 min of PET data with the Logan graphical method (Logan et al., 1996). This method yields BP estimates relative to non-displaceable (ND) binding, which is denoted by BPND (Innis et al., 2007). Global cortical mean PiB-BPND was evaluated from the measured brain regions.
2.4. MRI data analysis of T1w/T2w images
T1w and T2w images were preprocessed and combined using a dedicated workflow as described in the previous papers by Ganzetti et al., 2014, Ganzetti et al., 2015. This includes bias correction and intensity calibration on each of the two images and the subsequent calculation of the ratio between preprocessed T1w and T2w images. The entire processing of the T1w/T2w image was conducted using the MR Tool–Multimodal Mapping (http://www.bindgroup.eu/wp-content/uploads/2015/11/mrtool-v1.2.zip) implemented in the SPM12 software (Wellcome Trust Centre for Neuroimaging, London, UK).
Initially, the original T2w image was coregistered to the T1w image through a rigid-body transformation. Then, the T1w and T2w images were separately subjected to bias correction. The input parameters for the bias correction algorithm, namely the smoothing and the regularization parameters, were set at their default value. After correcting for intensity non-uniformity, the T1w and T2w images were further processed to standardize their intensity by using a linear scaling procedure systematically described in Ganzetti et al., 2014, Ganzetti et al., 2015. Eventually, after calibrating the T1w and T2w images, their ratio was calculated to generate the calibrated T1w/T2w image. To conduct statistical comparisons between groups, we spatially transformed the T1w/T2w image in subject space to the Montreal Neurological Institute space. The gray matter (GM) and white matter (WM) components of the T1w/T2w image were extracted using the segmented normalized T1w image. We created both GM and WM binary mask images using the SPM Masking Toolbox (Ridgway et al., 2009). These mask images were used to perform the statistical analyses with SPM12.
2.5. Statistical analysis
The subjects were divided into low and high PiB-BPND groups according to the global cortical mean PiB-BPND. We regarded subjects with PiB-BPND < 0.20 as the low PiB-BPND group (n = 25) and those with PiB-BPND ≥ 0.20 as the high PiB-BPND group (n = 13). Group differences in demographic characteristics between the low and high PiB-BPND groups were examined by unpaired t-test and Pearson's χ2 test.
Group differences in regional T1w/T2w values were compared using repeated measures analysis of variance (ANOVA) with a Huynh-Feldt's correction. A follow-up t-test was performed on the T1w/T2w values of each measured region in the two PiB-BPND groups. Although we found significant differences in sex and education between the groups, we did not include these as covariates due to the lack of a significant linear relationship with regional PiB-BPND. In the regions where we found a significant difference of T1w/T2w values between groups, we conducted a correlation analysis between the regional T1w/T2w values and PiB-BPND by Spearman correlation tests.
Voxel-based analysis was performed using the SPM12 software. Both GM and WM T1w/T2w images were smoothed with a Gaussian kernel of 6-mm full-width at half-maximum (FWHM). The difference in GM and WM T1w/T2w values between groups of low and high PiB-BPND was examined using ANOVA. Multiple comparisons were controlled with cluster-extent threshold combined with a height threshold of 0.001, to produce clusters with a family-wise error of p < 0.05. Spherical VOIs (5-mm radius) were determined from regions in which subjects with high PiB-BPND showed significantly higher or lower T1w/T2w values than subjects with low PiB-BPND. The center of the spherical VOIs was determined from the Montreal Neurological Institute coordinates with peak t-value. The regional T1w/T2w values were calculated by averaging the values for all voxels within the spherical VOIs placed on T1w/T2w images. The differences of T1w/T2w values in spherical VOIs were examined by unpaired t-test. The relationships among T1w/T2w values, PiB-BPND in the spherical VOIs, and global cortical mean PiB-BPND were examined by Spearman correlation tests. Statistical tests were 2-tailed and significance was reported at α < 0.05. Statistical analysis of the data was performed using SPSS for Windows 22.0 (IBM Japan Inc., Tokyo, Japan).
3. Results
Table 1 summarizes the demographic and clinical characteristics of groups of low and high global cortical mean PiB-BPND. The groups differ significantly in sex and educational periods.
Table 1.
Characteristic/test | Low PiB-BPND (BP < 0.20) |
High PiB-BPND (BP ≥ 0.20) |
t or χ2 | p |
---|---|---|---|---|
No. | 25 | 13 | ||
Global cortical mean PiB-BPND | 0.10 ± 0.07 | 0.40 ± 0.26 | 4.06 | 0.001a |
Age, years | 70.2 ± 6.9 | 70.8 ± 7.0 | 0.24 | 0.810 |
Sex M/F | 19/6 | 4/9 | 7.32 | 0.007a |
Education, years | 14.4 ± 2.5 | 11.7 ± 2.3 | 3.27 | 0.002a |
Mini-mental state examination | 29.3 ± 0.9 | 29.5 ± 1.1 | 0.54 | 0.590 |
Data are represented as mean ± sd.
p < 0.05.
In the repeated measures ANOVA, we found significant interaction between measured regions and the low/high groups of PiB-BPND (Table 2), and the follow-up t-test indicated that subjects with high global cortical PiB-BPND showed significantly higher regional T1w/T2w ratio in the orbital frontal cortex, lateral prefrontal cortex, medial frontal cortex, and anterior cingulate cortex (Table 2). Although we found significant differences in sex and education between groups, we did not include them as covariates due to the lack of their significant linear relationship with regional PiB-BPND.
Table 2.
Regions | T1w/T2w ratio |
t-Testa |
||
---|---|---|---|---|
Low PiB-BPND (N = 25) (BP < 0.20) |
High PiB-BPND (N = 13) (BP ≥ 0.20) |
t (1, 31) | p | |
Orbital frontal cortex | 0.78 ± 0.06 | 0.84 ± 0.08 | 2.54 | 0.02b |
Lateral prefrontal cortex | 0.70 ± 0.06 | 0.74 ± 0.05 | 2.10 | 0.04b |
Medial prefrontal cortex | 0.64 ± 0.05 | 0.68 ± 0.04 | 2.63 | 0.01b |
Lateral temporal cortex | 0.76 ± 0.05 | 0.79 ± 0.04 | 1.69 | 0.10 |
Medial temporal cortex | 0.70 ± 0.05 | 0.73 ± 0.03 | 1.72 | 0.09 |
Parietal cortex | 0.71 ± 0.05 | 0.70 ± 0.06 | 0.05 | 0.96 |
Occipital cortex | 0.76 ± 0.06 | 0.77 ± 0.05 | 0.50 | 0.62 |
Striatum | 0.90 ± 0.06 | 0.93 ± 0.05 | 1.38 | 0.18 |
Anterior cingulate cortex | 0.63 ± 0.04 | 0.66 ± 0.04 | 2.48 | 0.02b |
Posterior cingulate cortex | 0.69 ± 0.04 | 0.72 ± 0.05 | 1.96 | 0.06 |
Repeated measures of analysis of variance revealed a significant interaction of regions × groups of low/high PiB-BPND (regions, F = 235.4, df = 3.6, 128.2, p < 0.01, regions × groups of low/high PiB-BPND; F = 2.54, df = 3.6, 128.2, p = 0.05, groups of low/high PiB-BPND; F = 3.87, df = 1, 36, p = 0.06).
p < 0.05.
In the correlation analysis between the regional T1w/T2w ratio and PiB-BPND, we found a significant correlation between these values in the medial frontal cortex and in the combined region analysis (Table 3).
Table 3.
Spearman's ρ (p) | |
---|---|
Orbital frontal cortex | 0.21 (0.21) |
Lateral prefrontal cortex | 0.24 (0.14) |
Medial prefrontal cortex | 0.54 (0.0005)a |
Anterior cingulate cortex | 0.25 (0.13) |
Combination of the above regions | 0.45 (0.005)a |
Significant with consideration to the multiple comparisons with p < 0.01 (0.05/5).
In the voxel-based analysis, patients with high PiB-BPND values showed significantly higher GM T1w/T2w ratios in the medial frontal region (x = 4, y = 60, z = − 8) than patients with low PiB-BPND values (0.53 ± 0.04 in the low, 0.65 ± 0.11 in the high PiB-BPND group in the spherical VOI, t = 3.93, p = 0.001) (Fig. 1). We found no significant difference in WM T1w/T2w ratios between groups. After correcting the bias and calibrating the intensity, we compared GM T1w and T2w images in the medial frontal region between groups and found that T2w images in the high PiB-BPND group had significantly lower intensity (31.1 ± 2.6 in the low, 30.6 ± 2.6 in the high PiB-BPND group, t = 0.62, p = 0.54 for T1w images; 50.5 ± 4.3 in the low, 44.7 ± 5.8 in the high PiB-BPND group, t = 3.48, p = 0.001 for T2w images).
Scatter plots of the relationships among the T1w/T2w ratio and PiB-BPND in the spherical VOI in the medial prefrontal region and the global cortical mean PiB-BPND are shown in Fig. 2. We found significant correlations among regional T1w/T2w ratios, regional PiB-BPND values, and global cortical mean PiB-BPND values.
Fig. 3 shows the scatter plot of T1w/T2w ratio in the medial frontal region of the low and high PiB-BPND groups. We found a significant difference in the T1w/T2w ratios between the groups. We performed receiver operating characteristic curve (ROC) analysis to find the cut-off point of the T1w/T2w ratio that maximized sensitivity or specificity, which could best differentiate patients with low PiB-BPND from high PiB-BPND group members (Fig. 4). With a T1w/T2w ratio of 0.55, we correctly predicted 11 of 13 high PiB-BPND group members and 20 of 25 low PiB-BPND group members. The accuracy was 81.6%, with a sensitivity of 84.6% and specificity of 80.0% for the discrimination of subjects with high PiB-BPND from the total pool of subjects.
4. Discussion
In this present study, we evaluated the potential utility of the T1w/T2w approach for the prediction of Aβ deposition by the analysis of T1w and T2w data collected in cognitively normal subjects with low and high cortical Aβ accumulation. To our knowledge, this is the first in vivo study to show a relationship between the T1w/T2w ratio and amyloid pathology. We found larger T1w/T2w ratios in the high PiB-BPND group and a significant positive correlation between the T1w/T2w ratios and PiB-BPND values.
Our results support the notion that the ratio of T1w/T2w images could be a potentially sensitive marker of amyloid accumulation at the pre-clinical stage. However, the positive relationship between T1w/T2w ratio and the amyloid accumulation was contrary to expectations. If the T1w/T2w ratio were a reflection of the myelin-related pathological changes due to toxic Aβ accumulation, the T1w/T2w ratio should be decreased in accordance with the increase in Aβ accumulation. To interpret our results, it should be considered that the T1w/T2w image may reflect not only the level of demyelination but also other microstructural factors in addition to myelin. For example, iron, in addition to myelin, has been found to contribute to cortical MR image contrast (Shafee et al., 2015). Indeed, most metal deposition, including iron, causes high signal intensity on T1w images and/or low signal intensity on T2w images (Kanda et al., 2016). In the present study, we found that T2w images in the high PiB-BPND group had a significantly lower intensity compared to the low PiB-BPND group, and the increased T1w/T2w ratio is primarily due to differences in the T2w image.
Under normal conditions in healthy subjects, iron and myelin are colocalized in the cortex (Fukunaga et al., 2010), and the large fraction of the differences in T1w/T2w is thought to be due to variation of the myelin density (Shafee et al., 2015). However, recent reports provide strong evidence regarding the covariance of Aβ plaques with the heme-rich deposits found in the regions of the brain consistent with the pathological profile of neurodegeneration in AD (Raha et al., 2013). Iron complexed with Aβ peptides was indicated to be toxic in cultured cells (Schubert and Chevion, 1995). Iron was also shown to initiate and promote the aggregation, oligomerization, and amyloidosis of Aβ peptides (Huang et al., 2004, Liu et al., 2011, Mantyh et al., 1993). Thus, our finding of a positive relationship between the T1w/T2w ratio and Aβ deposition may reflect perturbations in the magnetic field due to plaque-attached iron strong enough to affect tissue susceptibility and MR relaxation times.
In vivo detection of amyloid plaques in humans by MRI opens up the possibility of the promising scenario of AD prevention. Here, we showed that the T1w/T2w ratio in the medial frontal cortex could classify 80.0% of subjects with low PiB-BPND and 84.6% of subjects with high PiB-BPND, with an accuracy of 81.6%. We believe that the T1w/T2w ratio is a potential stable biological marker of the early Aβ accumulation in cognitively normal individuals. As such, the T1w/T2w ratio method may aid the recruitment of subjects and the evaluation of the therapeutic efficacy in clinical settings and trials. Such a method of classifying Aβ-positivity improves the efficiency of the clinical trials by reducing subjects who need to be screened by CSF analysis or Aβ-PET. Our method is also useful for the identification of individuals with Aβ + deposits in the situation in which cost or a logistic problem prohibits Aβ detection by Aβ-PET scan or lumbar puncture.
The limitations of our study need to be considered. First, the sample size of our study was not large enough to detect small differences between the groups. Second, this was a cross-sectional and not a longitudinal follow-up study, which is necessary to see how predictive our findings are of future AD. Third, when we focused on three outliers with high regional T1w/T2w values in Fig. 2, these values seem to be overestimated when compared to those predicted from their PiB-BPND in plots without these outliers. This overestimation might be due to other confounding factors that affect the T1w/T2w values besides the known iron and myelin-related pathological changes. Before the clinical application of the T1w/T2w ratio method, future studies should determine the possible factors other than the iron and myelin content that affect the T1w/T2w ratio in MRI.
5. Conclusions
Our results showed that early Aβ deposits can be detected using the T1w/T2w ratio in MRI. We found a significant positive relationship between the regional T1w/T2w ratio and Aβ accumulation. This method is an attractive candidate for an inexpensive and noninvasive surrogate biomarker of Aβ accumulation because it is available widely and is routinely evaluated in clinical practice. The relatively short scan times and conventional protocols also increase the utility of this method in the clinical situation. Whereas it would be premature to draw definitive conclusions from the current analysis, our findings serve as promising pilot data for future studies.
Conflict of interests
All authors declare that there are no competing interests.
Funding
This research was supported by Grants-in-Aid for Scientific Research (C) 15K09841 from the Japan Society for the Promotion of Science. The funding body had no role in this study or its publication.
Acknowledgements
We thank Yuko Yamamoto in the Department of Neuropsychiatry at Osaka University Medical School for the recruitment and care of participants. We thank Akihide Shimizu, Yusuke Terakawa, Keiji Matsumuro, and the members of the PET staff of the Department of Radiology at the National Cerebral and Cardiovascular Center for carrying out the acquisition of PET data.
References
- Bateman R.J., Xiong C., Benzinger T.L., Fagan A.M., Goate A., Fox N.C., Marcus D.S., Cairns N.J., Xie X., Blazey T.M., Holtzman D.M., Santacruz A., Buckles V., Oliver A., Moulder K., Aisen P.S., Ghetti B., Klunk W.E., McDade E., Martins R.N., Masters C.L., Mayeux R., Ringman J.M., Rossor M.N., Schofield P.R., Sperling R.A., Salloway S., Morris J.C. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N. Engl. J. Med. 2012;367:795–804. doi: 10.1056/NEJMoa1202753. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fukunaga M., Li T.Q., van Gelderen P., de Zwart J.A., Shmueli K., Yao B., Lee J., Maric D., Aronova M.A., Zhang G., Leapman R.D., Schenck J.F., Merkle H., Duyn J.H. Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast. Proc. Natl. Acad. Sci. U. S. A. 2010;107:3834–3839. doi: 10.1073/pnas.0911177107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ganzetti M., Wenderoth N., Mantini D. Whole brain myelin mapping using T1- and T2-weighted MR imaging data. Front. Hum. Neurosci. 2014;8:671. doi: 10.3389/fnhum.2014.00671. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ganzetti M., Wenderoth N., Mantini D. Mapping pathological changes in brain structure by combining T1- and T2-weighted MR imaging data. Neuroradiology. 2015;57:917–928. doi: 10.1007/s00234-015-1550-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Glasser M.F., Van Essen D.C. Mapping human cortical areas in vivo based on myelin content as revealed by T1- and T2-weighted MRI. J. Neurosci. 2011;31:11597–11616. doi: 10.1523/JNEUROSCI.2180-11.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hardy J.A., Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science. 1992;256:184–185. doi: 10.1126/science.1566067. [DOI] [PubMed] [Google Scholar]
- Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002;297:353–356. doi: 10.1126/science.1072994. [DOI] [PubMed] [Google Scholar]
- Huang X., Atwood C.S., Moir R.D., Hartshorn M.A., Tanzi R.E., Bush A.I. Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides. J. Biol. Inorg. Chem. 2004;9:954–960. doi: 10.1007/s00775-004-0602-8. [DOI] [PubMed] [Google Scholar]
- Innis R.B., Cunningham V.J., Delforge J., Fujita M., Gjedde A., Gunn R.N., Holden J., Houle S., Huang S.C., Ichise M., Iida H., Ito H., Kimura Y., Koeppe R.A., Knudsen G.M., Knuuti J., Lammertsma A.A., Laruelle M., Logan J., Maguire R.P., Mintun M.A., Morris E.D., Parsey R., Price J.C., Slifstein M., Sossi V., Suhara T., Votaw J.R., Wong D.F., Carson R.E. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J. Cereb. Blood Flow Metab. 2007;27:1533–1539. doi: 10.1038/sj.jcbfm.9600493. [DOI] [PubMed] [Google Scholar]
- Iwatani J., Ishida T., Donishi T., Ukai S., Shinosaki K., Terada M., Kaneoke Y. Use of T1-weighted/T2-weighted magnetic resonance ratio images to elucidate changes in the schizophrenic brain. Brain Behav. 2015;5 doi: 10.1002/brb3.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jack C.R., Jr., Knopman D.S., Jagust W.J., Petersen R.C., Weiner M.W., Aisen P.S., Shaw L.M., Vemuri P., Wiste H.J., Weigand S.D., Lesnick T.G., Pankratz V.S., Donohue M.C., Trojanowski J.Q. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12:207–216. doi: 10.1016/S1474-4422(12)70291-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kanda T., Nakai Y., Aoki S., Oba H., Toyoda K., Kitajima K., Furui S. Contribution of metals to brain MR signal intensity: review articles. Jpn. J. Radiol. 2016;34:258–266. doi: 10.1007/s11604-016-0532-8. [DOI] [PubMed] [Google Scholar]
- Liu B., Moloney A., Meehan S., Morris K., Thomas S.E., Serpell L.C., Hider R., Marciniak S.J., Lomas D.A., Crowther D.C. Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation. J. Biol. Chem. 2011;286:4248–4256. doi: 10.1074/jbc.M110.158980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Logan J., Fowler J.S., Volkow N.D., Wang G.J., Ding Y.S., Alexoff D.L. Distribution volume ratios without blood sampling from graphical analysis of PET data. J. Cereb. Blood Flow Metab. 1996;16:834–840. doi: 10.1097/00004647-199609000-00008. [DOI] [PubMed] [Google Scholar]
- Mantyh P.W., Ghilardi J.R., Rogers S., DeMaster E., Allen C.J., Stimson E.R., Maggio J.E. Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide. J. Neurochem. 1993;61:1171–1174. doi: 10.1111/j.1471-4159.1993.tb03639.x. [DOI] [PubMed] [Google Scholar]
- Muller-Gartner H.W., Links J.M., Prince J.L., Bryan R.N., McVeigh E., Leal J.P., Davatzikos C., Frost J.J. Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. J. Cereb. Blood Flow Metab. 1992;12:571–583. doi: 10.1038/jcbfm.1992.81. [DOI] [PubMed] [Google Scholar]
- Raha A.A., Vaishnav R.A., Friedland R.P., Bomford A., Raha-Chowdhury R. The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer's disease. Acta Neuropathol. Commun. 2013;1:55. doi: 10.1186/2051-5960-1-55. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ridgway G.R., Omar R., Ourselin S., Hill D.L., Warren J.D., Fox N.C. Issues with threshold masking in voxel-based morphometry of atrophied brains. NeuroImage. 2009;44:99–111. doi: 10.1016/j.neuroimage.2008.08.045. [DOI] [PubMed] [Google Scholar]
- Schubert D., Chevion M. The role of iron in beta amyloid toxicity. Biochem. Biophys. Res. Commun. 1995;216:702–707. doi: 10.1006/bbrc.1995.2678. [DOI] [PubMed] [Google Scholar]
- Shafee R., Buckner R.L., Fischl B. Gray matter myelination of 1555 human brains using partial volume corrected MRI images. NeuroImage. 2015;105:473–485. doi: 10.1016/j.neuroimage.2014.10.054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tosun D., Joshi S., Weiner M.W. Multimodal MRI-based imputation of the Abeta + in early mild cognitive impairment. Ann. Clin. Transl. Neurol. 2014;1:160–170. doi: 10.1002/acn3.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yasuno F., Hasnine A.H., Suhara T., Ichimiya T., Sudo Y., Inoue M., Takano A., Ou T., Ando T., Toyama H. Template-based method for multiple volumes of interest of human brain PET images. NeuroImage. 2002;16:577–586. doi: 10.1006/nimg.2002.1120. [DOI] [PubMed] [Google Scholar]
- Yasuno F., Kazui H., Morita N., Kajimoto K., Ihara M., Taguchi A., Yamamoto A., Matsuoka K., Kosaka J., Kudo T., Iida H., Kishimoto T., Nagatsuka K. High amyloid-beta deposition related to depressive symptoms in older individuals with normal cognition: a pilot study. Int. J. Geriatr. Psychiatry. 2016;31:920–928. doi: 10.1002/gps.4409. [DOI] [PubMed] [Google Scholar]